BRVE SCHEDULE 13G: SEC filing

Filed with the SEC on · accession 0001193125-26-462144

BRVE filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -0.7% by the first close after the filing.

Summary of the filing

Forbion Growth Opportunities Fund III Cooperatief U.A. and affiliated entities filed a Schedule 13G disclosing beneficial ownership of approximately 12.9% and 11.3% of Braveheart Bio's common stock, respectively.

Key details

Shares of Common Stock beneficially owned by Forbion Growth III COOP$11.6M
Shares of Common Stock beneficially owned by Forbion VII COOP$10.2M
Total shares of Common Stock outstanding as of September 3, 2026$90.0M
Reporting person / beneficial ownerForbion Growth Opportunities Fund III Cooperatief U.A.
Reporting person / director of forbion growth iii coopForbion Growth III Management B.V.
Reporting person / beneficial ownerForbion Ventures Fund VII Cooperatief U.A.
Reporting person / director of forbion vii coopForbion Ventures VII Management B.V.
IssuerBraveheart Bio, Inc.

How BRVE stock reacted

Close before

$19.62

Nov 13, 2026

First close after

-0.66%

$19.49

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for BRVE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BRVE?

Click here

Frequently asked questions

What did BRVE file with the SEC on Nov 16, 2026?

BRVE filed a SCHEDULE 13G (SEC filing). Forbion Growth Opportunities Fund III Cooperatief U.A. and affiliated entities filed a Schedule 13G disclosing beneficial ownership of approximately 12.9% and 11.3% of Braveheart Bio's common stock, respectively.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did BRVE stock react to this filing?

BRVE closed at $19.62 before the filing and $19.49 on Nov 16, 2026 (-0.66%).

Other BRVE SEC filings

Get alerts when BRVE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days